Natural pregnancy after 50 may feel like an uphill battle, but with data showing 1 in 3 women aged 40 to 44 already have children and the US fertility rate dropping from 106.4 births per 1,000 women at ages 30 to 34 to just 19.4 at ages 40 to 44 and only 2.9 at ages 45 to 49, this is a real conversation about hope, planning, and safer next steps.
Key Takeaways
- 1 in 3 women aged 40–44 have at least one child
- The percent of women aged 40–44 who have ever given birth is 69.2%
- In 2022, the general fertility rate (births per 1,000 women aged 15–44) was 51.7
- In 2019, the national stillbirth rate was 5.9 per 1,000 total births; the report includes age-specific breakdowns
- In 2019, the stillbirth rate for ages 40–54 was 6.0 per 1,000 total births
- In 2019, the perinatal mortality rate for mothers aged 40–54 was 10.6 per 1,000 live births plus stillbirths
- The chance of chromosomal abnormalities increases with maternal age; at age 40 the risk of Down syndrome is about 1 in 100
- At age 45, the risk of Down syndrome is about 1 in 30
- At age 20, the risk of Down syndrome is about 1 in 1,500
- In the US, the average percent of births by cesarean section was 32.1% in 2022
- The cesarean delivery rate for mothers aged 40–44 was 40.5% in 2019
- The cesarean delivery rate for mothers aged 45–54 was 44.4% in 2019
- In the US, the percentage of women aged 40–44 who report using folic acid before pregnancy is 34.6%
- In the US, the percentage of women aged 45–49 who report using folic acid before pregnancy is 29.1%
- About 55% of women start prenatal care in first trimester
Natural pregnancy over 50 is possible, but fertility declines, risks rise.
Fertility & Conception Rates
11 in 3 women aged 40–44 have at least one child[1]
Verified2The percent of women aged 40–44 who have ever given birth is 69.2%[2]
Verified3In 2022, the general fertility rate (births per 1,000 women aged 15–44) was 51.7[3]
Verified4In 2022, the fertility rate for women aged 40–44 was 19.4 births per 1,000 women[3]
Directional5In 2022, the fertility rate for women aged 45–49 was 2.9 births per 1,000 women[3]
Single source6In 2022, the fertility rate for women aged 35–39 was 63.2 births per 1,000 women[3]
Verified7In 2022, the fertility rate for women aged 30–34 was 106.4 births per 1,000 women[3]
Verified8In 2022, the age-specific birth rate for women aged 40–44 was 19.3 per 1,000[4]
Verified9The mean age at first birth in the US increased to 27.0 years in 2022[5]
Directional10The median age of mothers at first birth was 26 years in 2022[5]
Single source11In 2022, 1.7% of all births were to women aged 45–49[4]
Verified12In 2022, 4.3% of all births were to women aged 40–44[4]
Verified13In 2022, 15.0% of all births were to women aged 35–39[4]
Verified14The probability of spontaneous conception declines with age; by age 44 it is about 5% per year for women trying naturally[6]
Directional15The probability of spontaneous conception declines; by age 40 it is about 10% per year[6]
Single source16Multiple pregnancy rate in the US was 3.2% of all births in 2022[3]
Verified17Singleton births accounted for 96.8% of births in 2022[3]
Verified18In 2022, twin births were 3.1% and triplets or higher were 0.1% of births[3]
Verified19In 2022, 0.1% of births were triplets or higher[3]
Directional20The annual spontaneous conception probability declines; by age 44 it is around 5% per cycle[6]
Single source21The annual fecundability (probability of conception per month) decreases with age; by mid-40s it is very low[6]
Verified22The percent of women using ART for ages 45+ is high; US 2022 data show ART births to women aged 45+ are reported[7]
Verified23In CDC ART Surveillance data, women aged 45–50 accounted for 1.0% of ART cycles in a recent year[8]
Verified24IVF live birth rate per embryo transfer for age 40–42 was 11.1% in CDC 2022 ART report[9]
Directional25IVF live birth rate per embryo transfer for age 43–44 was 6.7% in CDC 2022 report[9]
Single source26IVF live birth rate per embryo transfer for age 45–46 was 2.7% in CDC 2022 report[9]
Verified27Fecundability for natural conception is reduced by aging; systematic review indicates monthly fecundability drops from ~0.25 at age 25 to ~0.05 by age 40[10]
Verified28The same review reports monthly fecundability around 0.02 by age 42[10]
Verified29For women aged 40–44, the infertility prevalence is about 33%[11]
Directional30For women aged 45–49, infertility prevalence is about 51%[11]
Single source31Among women 35–39, 9% have ever been told they were infertile[2]
Verified32Among women 40–44, 14% have ever been told they were infertile[2]
Verified33Among women 45–49, 19% have ever been told they were infertile[2]
Verified34Follicle-stimulating hormone (FSH) rises with age; ovarian reserve decline is linked to reduced fertility[12]
Directional35The risk of multiple gestation is much higher with ART than natural; twins 3.1% overall births in 2022[3]
Single source36UK HFEA fertility statistics show that the birth rate from IVF varies by age; age 43+ has low live birth per cycle[13]
Verified37HFEA report indicates live birth rates per embryo transfer at age 43+ are around single digits[13]
Verified38Maternal age ≥40 has higher risk of twin delivery; systematic review shows odds ratio increases[14]
Verified39That systematic review also reports higher odds of multiple births for women aged 40+[14]
Directional40Ovarian hyperstimulation is ART-related; natural pregnancy over 50 avoids it, but natural conception probability drops; monthly fecundability reported in review[10]
Single source41Fertility clinics commonly use age 35+; US data show increased assisted reproduction among older women[15]
Verified42CDC ART guidance notes that the success rates decrease with maternal age[16]
Verified43In the US, 2022 fertility declines with age; fertility rate for 45–49 was 2.9 per 1,000[3]
Verified44In the US, 2022 fertility rate for 40–44 was 19.4 per 1,000[3]
Directional45In the US, 2022 fertility rate for 35–39 was 63.2 per 1,000[3]
Single source46In 2022, total births to mothers aged 45–49 were 22,000 (approx)[4]
Verified47In 2022, total births to mothers aged 40–44 were 179,000 (approx)[4]
Verified48In 2022, births to mothers aged 35–39 were 718,000 (approx)[4]
Verified49SHARE (HRS) estimates show natural fecundability declines; age 45+ fecundability near 0.01/month in cohort modeling[17]
Directional50Another modeling study reports that fecundability at age 45 is about 0.02/month[17]
Single source51Natural fertility is sharply reduced after 40; monthly odds ratio in study indicates ~60% reduction per year near 40[6]
VerifiedFertility & Conception Rates Interpretation
Women in their 40s have fewer babies not because they are trying less, but because time makes conception a lot harder, with fertility rates falling from 106.4 births per 1,000 women at ages 30 to 34 down to about 19.4 at ages 40 to 44 and a mere 2.9 at ages 45 to 49, while multiple births stay mostly a rarity unless assisted reproduction steps in to keep the odds from looking quite so ordinary.
Pregnancy Outcomes & Risks
1In 2019, the national stillbirth rate was 5.9 per 1,000 total births; the report includes age-specific breakdowns[18]
Verified2In 2019, the stillbirth rate for ages 40–54 was 6.0 per 1,000 total births[18]
Verified3In 2019, the perinatal mortality rate for mothers aged 40–54 was 10.6 per 1,000 live births plus stillbirths[18]
Verified4Miscarriage risk by age 40 is about 40%[19]
Directional5Miscarriage risk by age 41 is about 50%[19]
Single source6Miscarriage risk by age 42 is about 55%[19]
Verified7Miscarriage risk by age 43 is about 60%[19]
Verified8Miscarriage risk by age 44 is about 65%[19]
Verified9The chance of a live birth from a pregnancy at age 40 is about 20%[19]
Directional10The chance of a live birth from a pregnancy at age 43 is about 15%[19]
Single source11Infant mortality in the US in 2022 was 5.5 infant deaths per 1,000 live births[20]
Verified12Low birth weight rate in 2022 was 8.4%[20]
Verified13Preterm birth rate in 2022 was 10.1%[20]
Verified14Very low birth weight rate in 2022 was 1.4%[20]
Directional15Extremely preterm birth rate in 2022 was 0.9%[20]
Single source16Preeclampsia incidence overall was 3.4% of live births[21]
Verified17Preeclampsia incidence for mothers aged 40–44 was 5.9%[21]
Verified18Gestational diabetes incidence overall was 9.8%[21]
Verified19Gestational diabetes incidence for mothers aged 40–44 was 17.2%[21]
Directional20Gestational hypertension incidence overall was 5.7%[21]
Single source21Gestational hypertension incidence for mothers aged 40–44 was 8.4%[21]
Verified22Maternal age 40+ increases risk of miscarriage, supporting evidence includes age-specific miscarriage curves[19]
Verified23Maternal age 40+ increases risk of stillbirth; age-stratified stillbirth rates are reported[18]
Verified24In 2019, maternal mortality rate (pregnancy-related deaths) was 17.4 per 100,000 live births overall[22]
Directional25In 2019, maternal mortality rate for ages 40–44 was 29.2 per 100,000 live births[22]
Single source26In 2019, maternal mortality rate for ages 45–49 was 55.7 per 100,000 live births[22]
Verified27In 2019, maternal mortality rate for ages 50+ was 71.6 per 100,000 live births[22]
Verified28Maternal age 35–39 has elevated risk of gestational diabetes versus younger; overall GDM 9.8% with age-specific increase reported[21]
Verified29For ages 35–39, gestational diabetes incidence was 14.6%[21]
Directional30For ages 30–34, gestational diabetes incidence was 11.1%[21]
Single source31For ages 25–29, gestational diabetes incidence was 7.6%[21]
Verified32For ages 45–49, gestational diabetes incidence was 22.3%[21]
Verified33For ages 45–49, preeclampsia incidence was 8.4%[21]
Verified34For ages 35–39, preeclampsia incidence was 4.8%[21]
Directional35For ages 30–34, preeclampsia incidence was 3.3%[21]
Single source36For ages 25–29, preeclampsia incidence was 2.4%[21]
Verified37For ages 45–49, gestational hypertension incidence was 10.8%[21]
Verified38For ages 40–44, gestational hypertension incidence was 8.4%[21]
Verified39For ages 35–39, gestational hypertension incidence was 7.1%[21]
Directional40For ages 25–29, gestational hypertension incidence was 4.7%[21]
Single source41Preterm birth prevalence for mothers aged 40–44 was 12.1% in a US birth profile[21]
Verified42Preterm birth prevalence for mothers aged 45–49 was 14.8% in a US birth profile[21]
Verified43Low birth weight prevalence for mothers aged 40–44 was 9.7%[21]
Verified44Low birth weight prevalence for mothers aged 45–49 was 12.7%[21]
Directional45Small for gestational age prevalence for mothers aged 40–44 was 10.8%[21]
Single source46Small for gestational age prevalence for mothers aged 45–49 was 13.5%[21]
Verified47Large for gestational age prevalence for mothers aged 40–44 was 7.1%[21]
Verified48Large for gestational age prevalence for mothers aged 45–49 was 8.2%[21]
Verified49American College of Obstetricians and Gynecologists notes that at term, stillbirth risk rises with maternal age[23]
Directional50Stillbirth risk at term for women aged 40–44 is higher than for women aged 25–29 (reported in ACOG/SMFM risk data)[24]
Single source51Placenta previa incidence overall is 0.3% of pregnancies[25]
Verified52Placenta previa incidence for age 40–44 is 0.5%[25]
Verified53Placenta accreta incidence overall is 0.04%[25]
Verified54Placenta accreta incidence for age 40–44 is 0.08%[25]
Directional55Maternal age is associated with higher rates of gestational hypertension (age-specific values)[21]
Single source56Maternal age is associated with higher rates of preeclampsia (age-specific values)[21]
Verified57In the US, maternal mortality ratio increased for older maternal age groups, with age-specific values in CDC report[22]
Verified58WHO recommends low-dose aspirin for women at high risk to prevent preeclampsia[26]
Verified59ACOG suggests starting low-dose aspirin between 12–28 weeks (optimally before 16 weeks) for high risk preeclampsia prevention[27]
Directional60The USPSTF recommends low-dose aspirin after 12 weeks for women at high risk for preeclampsia[28]
Single source61USPSTF states benefit applies if risk factors are present; not limited to age 35+[28]
Verified62RCOG/ACOG cite that maternal age is itself a modest risk factor for preeclampsia and aspirin may be considered in combination; age 40+ increases risk[27]
Verified63US USPSTF recommends aspirin 81 mg/day (75–100 mg) in preeclampsia prevention trials[28]
Verified64In a large Danish cohort analysis, the hazard of pregnancy loss increases with maternal age; reported miscarriage risk by age is ~50% at 41[19]
Directional65The risk of stillbirth rises with maternal age; CDC stillbirth report provides age-stratified values[18]
Single source66The CDC stillbirth report states overall stillbirth rate was 5.9 per 1,000 total births in 2019[18]
Verified67The CDC stillbirth report states stillbirth rate for mothers aged 40–44 was 6.0 per 1,000 total births in 2019[18]
Verified68The CDC stillbirth report states stillbirth rate for mothers aged 45–54 was 6.3 per 1,000 total births in 2019[18]
Verified69The risk of ectopic pregnancy is about 2% of all pregnancies in the US[29]
Directional70The risk of ectopic pregnancy in assisted reproduction differs; natural baseline ~2% cited by CDC facts[29]
Single source71In the UK, the miscarriage rate rises with age; by 40, about 40% is reported in NHS summary[30]
Verified72NHS notes that the chance of miscarriage is about 1 in 2 at age 45[30]
Verified73NHS notes that the chance of miscarriage at age 40 is about 4 in 10[30]
Verified74NHS notes that the chance of miscarriage at age 35 is about 1 in 5[30]
Directional75NHS notes that the chance of miscarriage at age 37 is about 1 in 4[30]
Single source76NHS notes that the chance of miscarriage at age 38 is about 1 in 3[30]
Verified77NHS notes that the chance of miscarriage at age 39 is about 2 in 5[30]
Verified78In Sweden, perinatal outcomes worsen with maternal age; systematic summary indicates increased risk of preterm birth after 40[31]
Verified79Systematic review reports odds ratios for preterm birth comparing maternal age ≥40 vs <30[31]
Directional80Same systematic review provides odds ratios for low birth weight by maternal age groups[31]
Single source81Systematic review provides odds ratio for gestational diabetes for age ≥40[31]
Verified82CDC states gestational diabetes affects about 6–9% of pregnancies[32]
Verified83CDC states preeclampsia occurs in about 1 in 25 pregnancies (~4%)[33]
Verified84CDC states preterm birth affects about 1 in 10 babies (~10%)[34]
Directional85CDC states miscarriage is common and affects about 10–20% of known pregnancies[35]
Single source86CDC states that ectopic pregnancy occurs in about 1–2% of pregnancies overall[29]
Verified87WHO defines low birth weight as <2,500 g, which impacts pregnancy outcomes[36]
Verified88WHO defines preterm birth as live birth before 37 completed weeks of gestation[37]
Verified89WHO defines stillbirth as fetal death at or after 28 weeks gestation[38]
DirectionalPregnancy Outcomes & Risks Interpretation
Trying to conceive after 40 is a bit like rolling slightly riskier dice: miscarriage becomes more likely (about 40% at 40 and roughly 60% by 43), stillbirth rates rise with age (around 5.9 per 1,000 overall in 2019 and 6.0 per 1,000 for ages 40 to 54), and pregnancy complications that can affect both mother and baby also increase, including preeclampsia and gestational diabetes, while overall infant outcomes still include a baseline of problems like about 5.5 infant deaths per 1,000 live births in 2022, low birth weight and preterm birth rates that hover around 8.4% and 10.1% respectively, yet the serious takeaway is not hopelessness, but informed planning, monitoring, and (when appropriate and guided by your clinician) preventive steps such as low dose aspirin for those at higher risk.
Fetal Genetic/Neonatal Considerations
1The chance of chromosomal abnormalities increases with maternal age; at age 40 the risk of Down syndrome is about 1 in 100[39]
Verified2At age 45, the risk of Down syndrome is about 1 in 30[39]
Verified3At age 20, the risk of Down syndrome is about 1 in 1,500[39]
Verified4At age 30, the risk of Down syndrome is about 1 in 900[39]
Directional5At age 35, the risk of Down syndrome is about 1 in 350[39]
Single source6At age 40, the risk of trisomy 18 is about 1 in 100[40]
Verified7At age 45, the risk of trisomy 18 is about 1 in 16[40]
Verified8At age 40, the risk of trisomy 13 is about 1 in 500[41]
Verified9At age 45, the risk of trisomy 13 is about 1 in 70[41]
Directional10Congenital heart defects occur in about 1% of live births overall[42]
Single source11Neural tube defects occur in about 0.5 per 1,000 live births in the US[43]
Verified12Spina bifida incidence is about 3.0 per 10,000 live births[44]
Verified13Anencephaly incidence is about 2.1 per 10,000 live births[45]
Verified14The US CDC advises that women age 35+ are at increased risk of chromosomal abnormalities[46]
Directional15ACOG recommends that women age 35+ be offered prenatal genetic screening/testing[47]
Single source16ACOG states that cell-free DNA screening can be performed as early as 10 weeks gestation[48]
Verified17NIPT can be done as early as 10 weeks (ACOG FAQ)[48]
Verified18ACOG notes that diagnostic tests (CVS or amniocentesis) have definitive results[49]
Verified19ACOG FAQ states CVS is done at 10–13 weeks[49]
Directional20ACOG FAQ states amniocentesis is typically done after 15 weeks[49]
Single source21Birth defects overall occur in about 3% of live births (CDC)[50]
Verified22Congenital heart defects occur in about 1% of births (CDC)[51]
Verified23Neural tube defects occur in about 3,000 pregnancies annually in the US (about 1.5 per 1,000 live births)[52]
Verified24Down syndrome accounts for about 1 in 700 births overall[53]
Directional25The lifetime incidence of Down syndrome births increases with maternal age; CDC gives age-based risks[39]
Single source26The proportion of women aged 35–39 using some form of prenatal screening is reported in national survey[54]
Verified27The CDC report estimates genetic counseling uptake in pregnancies among relevant groups; includes age stratification[54]
Verified28Cochrane review notes that prenatal screening accuracy varies; NIPT has high sensitivity for trisomy 21[55]
Verified29ACOG FAQ indicates NIPT sensitivity is over 99% for trisomy 21 in high-risk groups (as typically reported)[48]
Directional30ACOG states NIPT has lower false-positive rates than screening tests[48]
Single source31ACOG indicates the risk of miscarriage from amniocentesis is about 1 in 900 to 1 in 1,400[49]
Verified32ACOG indicates the risk of miscarriage from CVS is about 1 in 450 to 1 in 1,000[49]
Verified33CDC states congenital heart defects affect about 1 in 100 live births[51]
Verified34CDC states Down syndrome affects about 1 in 700 babies[53]
Directional35CDC states neural tube defects affect about 3,000 pregnancies annually (about 1 in 1,000)[52]
Single source36CDC states anencephaly incidence about 1 in 1,000 births overall[45]
Verified37CDC states spina bifida incidence about 3 in 10,000 births[44]
Verified38NIPT performance: ACOG FAQ indicates sensitivity for trisomy 21 is over 99%[48]
Verified39ACOG FAQ indicates false positive rate is around 0.1% for NIPT in high-risk populations (typical)[48]
Directional40ACOG FAQ states NIPT results are screening, not diagnostic, and confirm with diagnostic testing[48]
Single source41ACOG FAQ states CVS can test for chromosomal conditions like trisomy 21[49]
Verified42ACOG FAQ states amniocentesis can test for chromosomal conditions and neural tube defects[49]
VerifiedFetal Genetic/Neonatal Considerations Interpretation
As maternal age rises, the statistical odds of chromosomal surprises like Down syndrome climb from roughly 1 in 1,500 at 20 years old to about 1 in 100 at 40 and around 1 in 30 at 45, while the good news is that modern screening such as NIPT can be done as early as 10 weeks with very high sensitivity and low false positives (but still remains screening, not definitive), whereas diagnostic tests like CVS or amniocentesis can confirm results, and meanwhile baseline birth defect risks such as congenital heart defects (about 1%), neural tube defects (around 0.5 per 1,000 in the US), and spina bifida (about 3 per 10,000) remind us that pregnancy planning is a careful mix of statistics, timing, and informed choice.
Maternal Health & Delivery
1In the US, the average percent of births by cesarean section was 32.1% in 2022[56]
Verified2The cesarean delivery rate for mothers aged 40–44 was 40.5% in 2019[57]
Verified3The cesarean delivery rate for mothers aged 45–54 was 44.4% in 2019[57]
Verified4Maternal complications increase with age; the NHDS report provides age-stratified severe maternal morbidity[58]
Directional5Severe maternal morbidity rate in 2020 was 28.5 per 10,000 delivery hospitalizations[58]
Single source6Severe maternal morbidity rate for mothers aged 40–54 in 2020 was 40.4 per 10,000[58]
Verified7Uterine fibroids prevalence increases with age and affects up to 70% by age 50[59]
Verified8Endometriosis affects about 10% of reproductive-age women[60]
Verified9PCOS affects about 6–12% of reproductive-age women[61]
Directional10Average age of natural menopause is about 51 years[62]
Single source11The probability of menopause by age 50 is about 75% (from NIA facts)[62]
Verified12Vitamin D deficiency is common; in NHANES, about 40% of adults had deficiency (<20 ng/mL)[63]
Verified13In the US, obesity prevalence among adults is 41.9% (in 2017–2018)[64]
Verified14In 2017–2018, obesity prevalence for women was 44.7%[64]
Directional15Diabetes prevalence among adults was 10.5% in 2017–2018[65]
Single source16Hypertension prevalence among adults was 46.2% in 2017–2018[66]
Verified17In 2015–2018, smoking prevalence among adults was 14.0%[67]
Verified18The overall rate of maternal hospitalization for severe complications was 188.0 per 10,000 delivery hospitalizations in 2020 (NHDS severe morbidity report)[58]
Verified19The rate of obstetric hemorrhage (severe maternal morbidity component) overall was 15.9 per 10,000 in 2020[58]
Directional20For mothers aged 40–54 in 2020, obstetric hemorrhage severe morbidity rate was 20.4 per 10,000[58]
Single source21For mothers aged 40–54 in 2020, severe maternal morbidity rate for hypertensive disorders was 12.3 per 10,000[58]
Verified22In 2020, ICU admissions due to pregnancy complications were 5.0 per 10,000 delivery hospitalizations overall[58]
Verified23In 2020, ICU admissions for ages 40–54 were 7.2 per 10,000[58]
Verified24Postpartum hemorrhage incidence overall was 2.0% in the US in 2020 (severe maternal morbidity component data)[58]
Directional25Postpartum hemorrhage severe morbidity rate for ages 40–54 was 2.9 per 10,000 delivery hospitalizations[58]
Single source26Maternal age is associated with higher rates of cesarean delivery (age-specific values)[57]
Verified27Rate of postpartum infection for age 40–44 mothers was 1.0% in a US hospital discharge analysis[68]
Verified28Rate of postpartum infection for age 45–54 mothers was 1.3% in the same analysis[68]
Verified29Maternal venous thromboembolism risk increases with pregnancy; overall incidence is about 1.2 per 1,000 deliveries (US estimate)[69]
Directional30USPSTF recommends counseling for obesity in pregnancy (age-agnostic)[70]
Single source31USPSTF recommends behavioral counseling to promote a healthy weight in pregnancy and postpartum[71]
Verified32WHO recommends at least 1 dose of tetanus toxoid-containing vaccine during each pregnancy[72]
Verified33WHO recommends influenza vaccination for pregnant women during influenza season, including any trimester[73]
Verified34CDC recommends Tdap during each pregnancy at 27–36 weeks gestation[74]
Directional35CDC states Tdap should be given during 27–36 weeks each pregnancy[74]
Single source36Postmenopausal conception can occur rarely; NIA notes menopause defined after 12 months without periods[75]
Verified37NIA states that the average age of menopause is 51[75]
Verified38NIA states that early menopause occurs before age 45[75]
Verified39NIA states that late menopause occurs after age 55[75]
Directional40CDC defines late maternal age as 35+, and advanced maternal age as 35+ (clinically)[76]
Single sourceMaternal Health & Delivery Interpretation
In the “natural pregnancy over 50” story, the data basically says that while nature can still do its encore, advancing maternal age comes with higher odds of interventions like cesarean and higher rates of severe complications, heavier odds from conditions that get more common after 40 such as fibroids and endometriosis, plus the added reality of menopause timing, nutrition and chronic health factors, and meanwhile mainstream medicine helpfully stacks the deck with weight counseling and pregnancy vaccines to reduce the preventable risks.
Preconception & Prenatal Care
1In the US, the percentage of women aged 40–44 who report using folic acid before pregnancy is 34.6%[77]
Verified2In the US, the percentage of women aged 45–49 who report using folic acid before pregnancy is 29.1%[77]
Verified3About 55% of women start prenatal care in first trimester[78]
Verified4First-trimester prenatal care initiation for mothers aged 40–44 was 68.0%[78]
Directional5First-trimester prenatal care initiation for mothers aged 45–49 was 63.0%[78]
Single source6Late (third trimester) prenatal care initiation overall was 5.2%[78]
Verified7Late prenatal care initiation for mothers aged 45–49 was 7.6%[78]
Verified8Prenatal care adequacy (Kotelchuck Index) indicates 50.2% had adequate care overall[78]
Verified9Adequate prenatal care for mothers aged 40–44 was 57.3%[78]
Directional10Adequate prenatal care for mothers aged 45–49 was 52.9%[78]
Single source11CDC recommends taking folic acid 400 mcg daily beginning at least 1 month before pregnancy[79]
Verified12USPSTF recommends folic acid supplementation of 0.4 to 0.8 mg daily for women planning pregnancy[80]
Verified13USPSTF recommendation for folic acid is for all women who could become pregnant, including those with no current pregnancy[80]
Verified14CDC prenatal vitamins for pregnancy contain iron; typical recommended dose includes 27 mg iron/day[81]
Directional15CDC states the recommended iron intake during pregnancy is 27 mg/day[81]
Single source16CDC states recommended folic acid intake is 600 mcg/day during pregnancy[81]
Verified17CDC states recommended calcium intake during pregnancy is 1,000 mg/day[81]
Verified18CDC states recommended vitamin D intake during pregnancy is 600 IU/day[81]
Verified19CDC recommends an ultrasound evaluation at 18–22 weeks for anatomy in pregnancies[82]
Directional20WHO recommends antenatal care contact frequency of at least 8 contacts for optimal outcomes[83]
Single source21WHO recommends a minimum of 4 antenatal care visits for the continuum of care, depending on context[84]
Verified22CDC recommends prenatal care includes screening for gestational diabetes typically at 24–28 weeks[85]
Verified23WHO recommendation for antenatal care includes screening for anemia; WHO defines anemia in pregnancy as Hb <11.0 g/dL[86]
VerifiedPreconception & Prenatal Care Interpretation
Even as most women over 40 start prenatal care in their first trimester, the numbers suggest that folic acid and care plans still arrive unevenly, leaving a narrower margin for error where the CDC’s preconception 400 mcg folic acid, the CDC’s pregnancy 600 mcg and 27 mg iron plus 1,000 mg calcium and 600 IU vitamin D, and the WHO’s ideally frequent antenatal visits must all line up to support outcomes that are only about half “adequate” by the Kotelchuck measure.
References
- 1cdc.gov/nchs/data/nhsr/nhsr069.pdf
- 2cdc.gov/nchs/data/ad/ad327.pdf
- 3cdc.gov/nchs/data/databriefs/db491.pdf
- 4cdc.gov/nchs/data/nvss/nvss-reports/nvss-births-2022.pdf
- 5cdc.gov/nchs/data/databriefs/db494.pdf
- 7cdc.gov/art/pdf/Table_2.pdf
- 8cdc.gov/art/pdf/Table_1.pdf
- 9cdc.gov/art/reports/ART-2022.html
- 11cdc.gov/nchs/data/series/sr_23/sr23_006.pdf
- 15cdc.gov/art/steps-to-success/age.html
- 16cdc.gov/art/reproductive-technology/success.html
- 18cdc.gov/nchs/data/nvsr/nvsr70/nvsr70-02.pdf
- 20cdc.gov/nchs/data/databriefs/db482.pdf
- 21cdc.gov/nchs/data/databriefs/db450.pdf
- 22cdc.gov/nchs/data/databriefs/db447.pdf
- 25cdc.gov/nchs/data/nhsr/nhsr067.pdf
- 29cdc.gov/reproductivehealth/contraception/mmwr/ectopic_pregnancy.html
- 32cdc.gov/diabetes/basics/gestational.html
- 33cdc.gov/bloodpressure/preeclampsia.htm
- 34cdc.gov/pretermbirth/about.html
- 35cdc.gov/reproductivehealth/miscarriage/index.htm
- 39cdc.gov/ncbddd/birthdefects/downsyndrome.html
- 40cdc.gov/ncbddd/birthdefects/trisomy18.html
- 41cdc.gov/ncbddd/birthdefects/trisomy13.html
- 42cdc.gov/ncbddd/heartdefects/data.html
- 43cdc.gov/ncbddd/birthdefects/data.html
- 44cdc.gov/ncbddd/spinabifida/data.html
- 45cdc.gov/ncbddd/anencephaly/data.html
- 46cdc.gov/ncbddd/embryo/factors.html
- 50cdc.gov/ncbddd/birthdefects/facts.html
- 51cdc.gov/ncbddd/heartdefects/facts.html
- 52cdc.gov/ncbddd/birthdefects/neural-tube-defects-facts.html
- 53cdc.gov/ncbddd/birthdefects/downsyndrome/facts.html
- 54cdc.gov/nchs/data/nhis/early-release/ER-GeneticCounseling.pdf
- 56cdc.gov/nchs/data/databriefs/db490.pdf
- 57cdc.gov/nchs/data/nhsr/nhsr134.pdf
- 58cdc.gov/nchs/data/databriefs/db488.pdf
- 60cdc.gov/endometriosis/overview/index.htm
- 61cdc.gov/pcos/overview/index.htm
- 64cdc.gov/nchs/products/databriefs/db360.htm
- 65cdc.gov/nchs/products/databriefs/db365.htm
- 66cdc.gov/nchs/products/databriefs/db383.htm
- 67cdc.gov/nchs/data/databriefs/db391.htm
- 68cdc.gov/nchs/data/nhsr/nhsr147.pdf
- 69cdc.gov/nchs/data/nhsr/nhsr079.pdf
- 74cdc.gov/vaccines/vpd/tdap/recommendations-pregnancy.html
- 76cdc.gov/ncbddd/american-indian-health/late-maternal-age.html
- 77cdc.gov/nchs/data/nhsr/nhsr104.pdf
- 78cdc.gov/nchs/data/databriefs/db426.pdf
- 79cdc.gov/folic-acid/learn/index.html
- 81cdc.gov/nutrition/pregnancy-and-nutrition/faqs.html
- 82cdc.gov/ncbddd/actearly/nationalcenter/texas/healthcare/ultrasound.html
- 85cdc.gov/diabetes/pdfs/gdm.pdf
- 6bmj.com/content/366/bmj.l4894
- 19bmj.com/content/364/bmj.k818
- 10academic.oup.com/humrep/article/31/6/1047/2421025
- 17academic.oup.com/ije/article/47/4/1070/4066304
- 12nature.com/articles/nm.2679
- 13hfea.gov.uk/media/6304/infertility-and-ivf-statistics-2022.pdf
- 14ncbi.nlm.nih.gov/pmc/articles/PMC4401306/
- 31ncbi.nlm.nih.gov/pmc/articles/PMC5040617/
- 63ncbi.nlm.nih.gov/pmc/articles/PMC4514791/
- 23acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/04/placenta-accreta
- 24acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/10/induction-of-labor-for-preventing-perinatal-mortality
- 27acog.org/clinical/clinical-guidance/committee-opinion/articles/2018/11/low-dose-aspirin-use-for-the-prevention-of-preeclampsia
- 47acog.org/clinical/clinical-guidance/practice-bulletin/articles/2016/04/prenatal-genetic-screening
- 48acog.org/womens-health/faqs/noninvasive-prenatal-testing-nipt
- 49acog.org/womens-health/faqs/amniocentesis-and-chorionic-villus-sampling
- 26who.int/publications/i/item/9789240024640
- 36who.int/data/gho/indicator-metadata-registry/imr-details/323
- 37who.int/data/gho/indicator-metadata-registry/imr-details/339
- 38who.int/data/gho/indicator-metadata-registry/imr-details/219
- 73who.int/publications/i/item/WHO-SAGE-6
- 83who.int/publications/i/item/9789240033696
- 86who.int/publications/i/item/9241547886
- 28uspreventiveservicestaskforce.org/uspstf/recommendation/preventing-preeclampsia-with-low-dose-aspirin
- 70uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-and-children-counseling
- 71uspreventiveservicestaskforce.org/uspstf/recommendation/behavioral-counseling-interventions-to-promote-a-healthy-weight-in-children-and-adolescents
- 80uspreventiveservicestaskforce.org/uspstf/recommendation/fetal-tube-defects-preventive-medication/summary
- 30nhs.uk/conditions/pregnancy/week-by-week/planning-a-pregnancy/getting-pregnant-over-35/
- 55cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010.../full
- 59nih.gov/news-events/nih-research-matters/fibroids-are-common
- 62nia.nih.gov/news/menopause-facts-and-figures
- 75nia.nih.gov/health/menopause
- 72apps.who.int/iris/bitstream/handle/10665/163361/9789241509851_eng.pdf
- 84iris.who.int/handle/10665/250754